These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 35561638)

  • 1. Status of radiobiology in molecular radionuclide therapy - Hope for the future.
    Nonnekens J; Pouget JP; Cornelissen B; Terry SYA; ;
    Nucl Med Biol; 2022; 110-111():45-46. PubMed ID: 35561638
    [No Abstract]   [Full Text] [Related]  

  • 2. Tumour therapy with radionuclides: assessment of progress and problems.
    Carlsson J; Forssell Aronsson E; Hietala SO; Stigbrand T; Tennvall J
    Radiother Oncol; 2003 Feb; 66(2):107-17. PubMed ID: 12648782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MIRD Pamphlet No. 22 (abridged): radiobiology and dosimetry of alpha-particle emitters for targeted radionuclide therapy.
    Sgouros G; Roeske JC; McDevitt MR; Palm S; Allen BJ; Fisher DR; Brill AB; Song H; Howell RW; Akabani G; ; Bolch WE; Brill AB; Fisher DR; Howell RW; Meredith RF; Sgouros G; Wessels BW; Zanzonico PB
    J Nucl Med; 2010 Feb; 51(2):311-28. PubMed ID: 20080889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Second Symposium of the European Working Group on the Radiobiology of Molecular Radionuclide Therapy.
    Nonnekens J; Cornelissen B; Terry SYA;
    J Nucl Med; 2023 Nov; 64(11):1788-1790. PubMed ID: 37442600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiobiologic principles in radionuclide therapy.
    Kassis AI; Adelstein SJ
    J Nucl Med; 2005 Jan; 46 Suppl 1():4S-12S. PubMed ID: 15653646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. From the target cell theory to a more integrated view of radiobiology in Targeted radionuclide therapy: The Montpellier group's experience.
    Pouget JP; Santoro L; Piron B; Paillas S; Ladjohounlou R; Pichard A; Poty S; Deshayes E; Constanzo J; Bardiès M
    Nucl Med Biol; 2022; 104-105():53-64. PubMed ID: 34922279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improving insight into radiobiology and radionuclide therapy.
    Goldsmith SJ
    J Nucl Med; 2004 Jul; 45(7):1104-5. PubMed ID: 15235053
    [No Abstract]   [Full Text] [Related]  

  • 8. The present and future role of monoclonal antibodies in the management of cancer. Summary.
    Brady LW; Markoe AM; Woo DV
    Front Radiat Ther Oncol; 1990; 24():247-59. PubMed ID: 2187762
    [No Abstract]   [Full Text] [Related]  

  • 9. Radiotargeting agents for cancer therapy.
    Kassis AI
    Expert Opin Drug Deliv; 2005 Nov; 2(6):981-91. PubMed ID: 16296803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The radiobiology of targeted radiotherapy.
    Wheldon TE; O'Donoghue JA
    Int J Radiat Biol; 1990 Jul; 58(1):1-21. PubMed ID: 1973428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The radiation biology of radioimmunotherapy.
    Dixon KL
    Nucl Med Commun; 2003 Sep; 24(9):951-7. PubMed ID: 12960593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relevance of radiobiological concepts in radionuclide therapy of cancer.
    Kumar C; Shetake N; Desai S; Kumar A; Samuel G; Pandey BN
    Int J Radiat Biol; 2016; 92(4):173-86. PubMed ID: 26917443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiation protection in therapy with radiopharmaceuticals.
    Hosono M
    Int J Radiat Biol; 2019 Oct; 95(10):1427-1430. PubMed ID: 30265162
    [No Abstract]   [Full Text] [Related]  

  • 14. Rationales, evidence, and design considerations for fractionated radioimmunotherapy.
    DeNardo GL; Schlom J; Buchsbaum DJ; Meredith RF; O'Donoghue JA; Sgouros G; Humm JL; DeNardo SJ
    Cancer; 2002 Feb; 94(4 Suppl):1332-48. PubMed ID: 11877764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current status of radioimmunoglobulins in the treatment of human malignancy.
    Order SE; Sleeper AM; Stillwagon GB; Klein TL; Leichner PK
    Oncology (Williston Park); 1989 May; 3(5):115-20; discussion 122, 129-30. PubMed ID: 2491440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radionuclides in radiation-induced bystander effect; may it share in radionuclide therapy?
    Widel M
    Neoplasma; 2017; 64(5):641-654. PubMed ID: 28592116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Possibilities of development of radioactive drugs].
    Mitchell JS
    Strahlenschutz Forsch Prax; 1970; 10():1-34. PubMed ID: 5522193
    [No Abstract]   [Full Text] [Related]  

  • 18. The Radiobiology of Radiopharmaceuticals.
    Morris ZS; Wang AZ; Knox SJ
    Semin Radiat Oncol; 2021 Jan; 31(1):20-27. PubMed ID: 33246632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiobiology as a basic and clinical medical science: what the physicists have forgotten.
    Corvò R; Santoni R; Magrini SM; Enrici RM
    Tumori; 2016 Feb; 102(1):e8. PubMed ID: 26350181
    [No Abstract]   [Full Text] [Related]  

  • 20. [Proceedings: German Roentgen Congress 1972. Abstracts of the 53d session of the German Roentgen Society for Medical Radiology, Radiobiology and Nuclear Medicine Inc., May 11-13, 1972 at Stuttgart].
    Fortschr Geb Rontgenstr Nuklearmed; 1973; ():Suppl:1-343. PubMed ID: 4148315
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.